OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 90 filers reported holding OLEMA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $853,000 | -81.7% | 200,300 | -59.8% | 0.01% | -81.1% |
| Q4 2021 | $4,666,000 | -72.3% | 498,517 | -18.3% | 0.04% | -72.0% |
| Q3 2021 | $16,817,000 | +105.6% | 610,194 | +108.7% | 0.13% | +112.9% |
| Q2 2021 | $8,179,000 | -0.3% | 292,323 | +18.3% | 0.06% | +1.6% |
| Q1 2021 | $8,201,000 | -32.7% | 247,171 | -2.4% | 0.06% | -35.1% |
| Q4 2020 | $12,181,000 | – | 253,354 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $15,238,000 | 2.80% |
| Fairmount Funds Management LLC | 2,669,300 | $10,864,000 | 2.49% |
| BVF INC/IL | 7,611,503 | $30,979,000 | 1.50% |
| Vivo Capital, LLC | 1,689,515 | $6,876,000 | 0.69% |
| Cormorant Asset Management, LP | 2,082,000 | $8,474,000 | 0.64% |
| Newtyn Management, LLC | 500,000 | $2,035,000 | 0.39% |
| Kynam Capital Management, LP | 249,229 | $1,014,000 | 0.26% |
| Monaco Asset Management SAM | 130,000 | $529,000 | 0.23% |
| TANG CAPITAL MANAGEMENT LLC | 318,926 | $1,298,000 | 0.20% |
| Artal Group S.A. | 260,500 | $1,060,000 | 0.06% |